In our previous study, matrine derivative (M19) protected liver fibrosis by targeted to RPS5 in hepatic stellate cells (HSCs) and RPS5 overexpression in HSCs resulted in activation of AKT pathway (Xu et al., 2014). The gene discussed is AKT1; the disease is Hepatic fibrosis.